Do Institutional Biosafety Committees (IBCs) have a role in the review of “dual use Research”?
At this time, the mandated roles and responsibilities of IBCs have not changed to include review of dual use research of concern. IBCs should continue to carry out the duties outlined in the NIH Guidelines for Research Involving Recombinant DNA Molecules and any others as determined by their institutions.
